Patients taking Wegovy typically see a 14.9% decrease in body weight after 68 weeks.
Category: Breaking
North Carolina Restricts Gender-Affirming Care After Overriding Governor’s Veto—Here Are All The States With Similar Bans Or Restrictions
The state joins more than a dozen others with legislation targeting transgender healthcare this year.
Opioid Crisis Worse Now Than Ever: Drug Overdose Deaths Spike Amid Fentanyl Surge
Deaths from cocaine and methamphetamine also rose sharply in 2021, CDC researchers warned, and the rate of deaths from fentanyl overdoses has nearly quadrupled in the five years between 2016 and 2021.
One-Hour Diabetes Procedure Offers Fresh Hope For Ditching Insulin
Early research suggests the nonsurgical outpatient procedure could help type 2 diabetics manage their condition without frequent insulin injections.
What To Know About ‘Arcturus’: New Covid Variant Causing Pink Eye
Arcturus (or XBB.1.16) is the second most prevalent subvariant, making up 9.6% of all U.S. Covid cases.
New Treatment For Pancreatic Cancer—The Most Lethal Of Cancers—Offers Hope
“I’ve never been more hopeful about the possibility of improving the survival rate for this disease,” said researcher Sana Karam, who noted the animal study could change the way doctors treat the condition in the “near future.”
Eli Lilly Pushes For Fast-Track Approval Of Mounjaro As Weight-Loss Drug
Late-stage trials suggest Lilly’s tirzepatide, sold under Mounjaro, could be a more effective obesity drug that Ozempic or Wegovy, and the company expects a regulatory decision by the end of the year.
Mifepristone: Supreme Court Keeps Abortion Pills Legal—At Least For Now—Blocking Ruling
The high court’s ruling means mifepristone’s approval will stay in place as the lawsuit against it plays out in court.
Moderna Partners With IBM Hoping AI Can Help Develop More mRNA Medicine
Moderna’s CEO said the partnership will allow the company to advance and accelerate its mRNA research and help it build a “quantum-ready workforce.”
Multiple Sclerosis Drug Shows Promise Preventing Earliest Symptoms Of Degenerative Disease
Early findings suggest the drug, which is already approved for MS symptoms, could slash the risk of people with no symptoms but who have signs of nerve damage on MRI scans.
